Mindray Medical (NYSE:MR) said today it completed the acquisition of the remaining stakes in Wuhan Dragonbio for a price of approximately $70.2 million. Shenzhen, China-based Mindray manufactures and markets patient monitoring and life support devices, in-vitro diagnostics and medical imaging systems, the company said. Mindray now holds 100% of the shares of Dragonbio, producer of orthopedic products […]
Mindray Medical International Ltd.
Mindray buys remaining stake in Dragonbio
Mindray Medical (NYSE:MR) said today it is acquiring the remaining stake in Wuhan Dragonbio for an estimated $72.6 million. Shenzhen, China-based Mindray manufactures and markets patient monitoring and life support devices, in-vitro diagnostics and medical imaging systems, the company said. “Since we acquired a majority stake of Dragonbio in 2012, the integration has been well on […]
Mindray committee to mull management’s takeover bid
Mindray Medical (NYSE:MR) said it formed a special committee to consider the $3.5 billion buyout offer made this month by its top executives. Co-CEOs Li Xiting and Cheng Minghe and chairman Xu Hang offered $30 per share for the Mindray stake they don’t already own. Today the company said it formed a committee of 3 independent directors to “exclusively evaluate […]
Pentagon picks up $60m option on Mindray contract
Analysts claim ‘smoking gun’ on alleged Mindray Medical fraud | MassDevice.com On Call
MASSDEVICE ON CALL — Analysts at short-seller Ottoman Bay Research, which have long held that Mindray Medical (NYSE:MR) management has misled investors, claim that they’ve found the so-called "smoking gun" that proves their accusations.
Short-seller takes another shot at Mindray Medical
Short-seller Ottoman Bay Research took another shot at Mindray Medical (NYSE:MR) this week, taking issue with the Chinese medical device company’s response to Ottoman’s initial accusations of fraud and mismanagement.
Mindray Medical on the rebound after fraud charges plunge share prices
Mindray settles unspecified Beckman Coulter beef for $15M
Mindray lowers full year guidance on slowdown in China
U.S. Defense Dept. awards $196M in contracts to medical device companies
The U.S. Defense Dept. awarded $195.8 million worth of contracts to 3 medical device firms.
CAZ Investments raises $29M fund | Wall Street Beat
CAZ Investments raised a nearly $29 million funding round it plans to use to back medical companies that already have products on the market.
The Houston-based asset management firm reeled in $28.7 million from 61 unnamed investors, according to a regulatory filing.
CAZ Investments chairman Christopher Zook said the firm plans to use the cash to invest in commercialized companies.